1.
Curr Med Chem
; 29(6): 958-959, 2022.
Article
in English
| MEDLINE | ID: covidwho-2253765
2.
Eur J Clin Invest
; : e13908, 2022 Nov 14.
Article
in English
| MEDLINE | ID: covidwho-2228565
3.
Ann Clin Transl Neurol
; 9(11): 1826-1831, 2022 Nov.
Article
in English
| MEDLINE | ID: covidwho-2074894
ABSTRACT
Increasing evidence suggests persistent cognitive dysfunction after COVID-19. In this cross-sectional study, frontal lobe function was assessed 12 months after the acute phase of the disease, using tailored eye tracking assessments. Individuals who recovered from COVID-19 made significantly more errors in all eye tracking tasks compared to age/sex-matched healthy controls. Furthermore, patients who were treated as inpatients performed worse compared to outpatients and controls. Our results show impaired inhibitory cortical control in individuals who recovered from COVID-19. The association between disease severity and its sequelae may contribute to a better understanding of post-COVID-19 cognitive function.
Subject(s)
COVID-19 , Cognition Disorders , Cognitive Dysfunction , Humans , Eye-Tracking Technology , Cross-Sectional Studies , COVID-19/complications , Cognitive Dysfunction/etiology
4.
Eur J Clin Invest
; 52(8): e13816, 2022 08.
Article
in English
| MEDLINE | ID: covidwho-1874411
5.
Eur J Clin Invest
; 52(4): e13734, 2022 Apr.
Article
in English
| MEDLINE | ID: covidwho-1583579
6.
Eur J Clin Invest
; 52(1): e13705, 2022 Jan.
Article
in English
| MEDLINE | ID: covidwho-1505731
7.
Eur J Clin Invest
; : e13302, 2020 Jun 07.
Article
in English
| MEDLINE | ID: covidwho-1388251
8.
Eur J Clin Invest
; 50(7): e13311, 2020 Jul.
Article
in English
| MEDLINE | ID: covidwho-574738